Nothing can be done in government- we hear it often. But is it true? Here is my first hand account of what I could do as government servant - promoting risk taking- the riskiest of all businesses.
At cross roads once again, people of Andhra are rediscovering their roots, their history, their strengths. This is a brief attempt to narrate History of Andhra from entrepreneurial perspective.
Nothing can be done in government- we hear it often. But is it true? Here is my first hand account of what I could do as government servant - promoting risk taking- the riskiest of all businesses.
At cross roads once again, people of Andhra are rediscovering their roots, their history, their strengths. This is a brief attempt to narrate History of Andhra from entrepreneurial perspective.
Measuring And Communication Risk The Fair Way Kevin Rigginskriggins
Two of the most important elements of a successful risk management practice are measuring and communicating risk. A repeatable, consistent framework for measuring risk is vital. We also need a way to communicate the results of those assessments to business partners in a manner relevant to them.
From the Factor Analysis of Information Risk whitepaper “FAIR provides a framework for understanding, analyzing, and measuring information risk. The outcomes are more cost-effective information risk management, greater credibility for the information security profession, and a foundation from which to develop a scientific approach to information risk management.”
This presentation will show how FAIR provides a common taxonomy for assessing risk, how it allows us to measure risk in a manner that is repeatable and supportable and finally how we can communicate that risk effectively.
Trabalho apresentado por alunos do 7º Ano da Escola Dr. Joaquim Marques Monteiro- Disciplina História.
Por terem sido salvos em formato de imagem, alguns erros não puderam ser corrigidos. O objetivo da realização foi a construção dos slides, o conteúdo, e a apresentação pelos alunos.
O objetivo foi a realização dos alunos na construção dos slides , o conteúdo e sua performac
World Health Organization Grants Prequalification to Bharat Biotech’s rotavir...BharatBiotechInterna
World Health Organization Grants Prequalification to Bharat Biotech’s rotavirus vaccine, ROTAVAC.Bharat Biotech is committed to make ROTAVAC® accessible and affordable for countries with highest burden of disease.This vaccine to prevent infant deaths and hospitalizations due to rotavirus diarrhea was launched by the Hon’ble Prime Minister of India, Shri Narendra Modi in New Delhi in March 2015 and is one of the first novel vaccines to be developed completely from a developing world country.
#BharatBiotech #Innovation #Lead #Rotavirus #ROTAVAC #WHO #worldhealthorganization #ROTA #Health #Biotech #Vaccine #Diarrhea #Disease
Blockchain & Healthcare | Strategy, Implications and Implementationaurablocks
What role can Blockchain technology have in Healthcare? How big of an impact can it have and how do you get started? A brief perspective is offered. AuraBlocks.com session at Oracle Open World 2018
Measuring And Communication Risk The Fair Way Kevin Rigginskriggins
Two of the most important elements of a successful risk management practice are measuring and communicating risk. A repeatable, consistent framework for measuring risk is vital. We also need a way to communicate the results of those assessments to business partners in a manner relevant to them.
From the Factor Analysis of Information Risk whitepaper “FAIR provides a framework for understanding, analyzing, and measuring information risk. The outcomes are more cost-effective information risk management, greater credibility for the information security profession, and a foundation from which to develop a scientific approach to information risk management.”
This presentation will show how FAIR provides a common taxonomy for assessing risk, how it allows us to measure risk in a manner that is repeatable and supportable and finally how we can communicate that risk effectively.
Trabalho apresentado por alunos do 7º Ano da Escola Dr. Joaquim Marques Monteiro- Disciplina História.
Por terem sido salvos em formato de imagem, alguns erros não puderam ser corrigidos. O objetivo da realização foi a construção dos slides, o conteúdo, e a apresentação pelos alunos.
O objetivo foi a realização dos alunos na construção dos slides , o conteúdo e sua performac
World Health Organization Grants Prequalification to Bharat Biotech’s rotavir...BharatBiotechInterna
World Health Organization Grants Prequalification to Bharat Biotech’s rotavirus vaccine, ROTAVAC.Bharat Biotech is committed to make ROTAVAC® accessible and affordable for countries with highest burden of disease.This vaccine to prevent infant deaths and hospitalizations due to rotavirus diarrhea was launched by the Hon’ble Prime Minister of India, Shri Narendra Modi in New Delhi in March 2015 and is one of the first novel vaccines to be developed completely from a developing world country.
#BharatBiotech #Innovation #Lead #Rotavirus #ROTAVAC #WHO #worldhealthorganization #ROTA #Health #Biotech #Vaccine #Diarrhea #Disease
Blockchain & Healthcare | Strategy, Implications and Implementationaurablocks
What role can Blockchain technology have in Healthcare? How big of an impact can it have and how do you get started? A brief perspective is offered. AuraBlocks.com session at Oracle Open World 2018
Presentation first given at the EphMRA 360 Future conference, Paris, June 19 - 21, 2012.
Explores current pharma market research opportunities on physicians' social networks in Europe, the Asia Pacific region and the USA.
Bad Data is No Better Than No Data - Impact of Automation in Data Stewardship...Karnam Vasudeva Rao, PhD
This presentation focuses on the below:How to convert D3 data (dirty, disconnected and disorganized) generated in plant agriculture industries into C3 data (clean, consistent and connected data) using programming. The second part is about machine learning In agriculture industries; its impact on optimization and system improvement, and the factors to be taken care while building models.
The related document describes the entire schedule of the 2 day conference, the key sessions, the topics covered etc. It also includes the Partners, Associations and Media Partners associated with this conference. For more details please visit:
www.ithealthcare.co.in
Research Data Alliance (RDA) Webinar: What do you really know about that anti...dkNET
What do you really know about that antibody? Ask dkNET
Research resources-defined here as the tools researchers use in their scientific studies-are a foundation of the biomedical enterprise. It is critical for researchers to be able to select the proper tools for their research, but also be aware of any issues that may arise in their application. Software tools and datasets may have bugs, cell lines get contaminated, knock outs may be incomplete and antibodies may have specificity problems. Such problematic resources can continue to be used in scientific studies, even after problems are detected. Many factors, including the inability to easily retrieve alerts about problematic resources, results in their continued use, wasting both time and money. To make it easy to find information about research resources and how they perform, dkNET (NIDDK Information Network, https://dknet.org), an on-line portal supported by the US National Institute of Diabetes, Digestive and Kidney diseases (NIDDK), has developed a resource information network that utilize Research Resource Identifiers (RRIDs) and natural language processes to aggregate information about individual antibodies, cell lines, organisms, digital tools, plasmids and biosamples. This information is presented in a Resource Report that provides information such as which papers have been published using these resources, who is using them and whether issues have been reported. Using this information, dkNET also provides tools to create authentication reports in support of the NIH rigor and reproducibility guidelines. The dkNET portal includes additional information to enable researchers to easily use and navigate large amounts of data and information about research resources in support of reproducible science.
By the end of this webinar, participants will be familiar with the services and tools provided at dkNET and will be able to create a detailed research resource report and produce an authentication report in support of NIH mandates and policies.
Presenter: Maryann Martone, PhD, FAIR Data Informatics Lab (FDI Lab), University of California, San Diego
Sample chapter from new book- Top 100 Indian Innovations (2022) published by Indian Innovators Association. All innovations are physical, embodied in Agriculture, water sanitation, defence, industrail, consumer etc
There are many opportunities for Indian entrepreneurs in agribusiness. This presentation relates opportunities to stage of innovation from Patent to Diffusion.
Is COVID crisis a turning point in industry- academic partnership in India? Innovations from CSIR labs, DRDO labs, IITs, R&D institutes of DST, DBT have found willing partners in Industry- start ups to established firms.
COVID Crisis unleashed creativity of Indian Researchers and Innovators like never before. Is India becoming an Innovation nation? Here, we look at basics of IPR and some of the COVID 19 innovations.
By all accounts Anthony Levandowsk was a great innovator whose contributions make Self Driving cars/ autonomous vehicles a reality. Did he err on the wrong side of law on trade secrets?
Generally speaking, there are three large categories of instruments used in public policy: 1) Regulatory instruments,
(2) Economic and financial instruments, and (3) Soft instruments. This three-fold typology of policy instruments is what has popularly been identified as the “sticks”, the “carrots” and the “sermons” of public policy instruments.
Innovation is demand driven. India is not home to any significant global innovation for the obvious reason -there is no demand for innovations in India. There is demand for innovative products/ services and they are met by imports. Preaching to private sector to invest in R&D has become an annual ritual. Declaration like Innovation Decade exposed hollowness of public policy. Will the government walk the talk?
While India is still struggling to come with a WTO compliant local content program , many countries, USA, Europe, Japan etc found a way to strategically use public procurement for promoting local innovations.
Risk averse India sends policy makers on global hunt for innovative solutions . Developed countries work to simulate innovations locally with public procurement policy.
Indian governments Fiscal incentives for R&D are among the most unimaginative and unresponsive in the world. See how other nations proliferated their support measures while still playing by the WTO rule book.
Innovation policy is a relatively new item on policy-makers’ agendas. t is only from the mid-1990s onwards that the term became popular among users. In generic terms, ‘innovation policy’ is traditionally conceived as a way to support the capability of countries or regions and their innovation systems in producing novelties and putting them to use. The academic and political debate about innovation policy has focused for decades on supporting the generation of innovations. This is best illustrated by the concepts and indicators used to assess and compare the innovativeness and competitiveness of countries, which concentrate primarily on supply-side conditions, activities, capabilities, and interactions. Moreover, innovation policy rational and policy instruments have been developed mainly in the context of developed countries.
Demand-side innovation policy instruments may be defined as a set of public measures to increase the demand for innovations, to improve the conditions for the uptake of innovations, and/or to improve the articulation of demand in order to spur innovations and the diffusion of innovations. Such a broad definition of demand-based innovation policies implies twin rationales, namely, to promote and stimulate innovation and to increase the diffusion of innovation. In addition, this second rationale, the diffusion of innovation, further implies that the concept of innovation extends beyond the scope of 'new to the world' and encompasses innovations that are `new to a firm’ or to a certain geographical space.
The end of long journey for researcher is completion of the project, evaluation by the peers, filing patent application and acceptance by funder. But critical next step is clarity that Patent is not Technology.
India International Innovation Fair held at Bangalore from 9th to 11th September 2016 provided an unique opportunity for young scientists ( school children) to join their seniors from 20 countries.
First India International Innovation Fair report ,
D N A Of Biopreneur
1. DNA of Biopreneur A.S.Rao Adviser-Innovation Clusters,FMC indiainvents@hotmail.com http://www.indiainvents.blogspot.com/
2. Molecule millionaires Scientist turned promoter: Dr Anji Reddy (DPR), Ketan R Patel(Troikka), Krishna Ella (Bharat Biotech), Ramanbhai Patel(Cadia), Biopreneurs: Ranbir Singh & Gurbax Singh (Ranbaxy), UN Mehta (Torrent), Varaprasad Reddy (Shanta Biotech), Raghavendrarao (Orchid)
3. Signature of success Master the virtuous cycle of knowledge management. Identify business opportunity, decipher key factors, relate to technology, acquire technology and raise the stock of Firm Specific Knowledge. Learn to network with knowledge partners and knowledge workers. Lead cluster formation as network orchestrator
5. Opportunities Patents not enforced in India Drugs going off the patents Affordable health care 100 global technologies shortlisted by knowledge partner Sky Quest.
6. Patents not enforced in India http://www.globalinnovationcommons.org Buruli Ulcer, Dengue Fever, Dracunculiasis(Guinea Worm Disease), Leprosy, Lymphatic Filariasis, Malaria, Sickle Cell Anemia, Snake Bite, Spider Bite
7. Going off the patent 22 drugs will go off-patent in India by 2015-Rituxan, an anti-neoplasticmAbs from Roche; Lantus, an antidiabetics from Sanofiaventis; and Neulasta, an immunostimulants from Amgen; have record sales of $5.6 billion, $4.3 billion and $3.4 billion respectively. Similarly, Epogen from Amgen, Avonex from Biogen Idec, Eprex from Johnson & Johnson and Rebif from Merck, which reported sales of over $2 billion in 2009, will lose patents by 2013.
8. Affordable health care Service innovations: Eye care, Heart surgery, Tele medicine, remote monitoring of patients, Reverse innovations: from Innovators/ start-ups –Mosquito traps, infant warmers Non-profit design centers: http://www.d-rev.org/index.html